NCT06545864View on ClinicalTrials.gov

Systemic Thrombolysis Versus Catheter Directed Management for Acute Intermediate-high Pulmonary Embolism

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

November 30, 2029

Study Completion Date

March 1, 2030

Conditions
Acute Pulmonary Embolism
Interventions
DRUG

Streptokinase Injection

250000 IU as a loading dose over 30 min. Followed by 100000 IU/hour over 12:24hours or accelerated regimen 1.5 million IU over 2 hours

DEVICE

Penumbra System

"which comprised of several devices:~* RED Reperfusion Catheters~* Penumbra JET Reperfusion Catheters~* ACE Reperfusion Catheters~* MAX Reperfusion Catheters~* 3D Revascularization Device~* Penumbra ENGINE Aspiration Source~* Penumbra ENGINE Canister~* Aspiration Tubing"

Trial Locations (1)

Unknown

Hospital University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06545864 - Systemic Thrombolysis Versus Catheter Directed Management for Acute Intermediate-high Pulmonary Embolism | Biotech Hunter | Biotech Hunter